These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 619265)

  • 61. Circulating immune complexes in systemic scleroderma.
    Swierczynska Z; Rdultowska H; Blaszczyk M; Jablonska S; Luft S
    Immunol Commun; 1984; 13(5):433-8. PubMed ID: 6335127
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum immunoglobulin and complement values in onyalai. Comparison with black, San and white inhabitants of Kavango, SWA/Namibia.
    Hesseling PB; Cooper RC; Girdle-Brown B
    S Afr Med J; 1986 Aug; 70(4):203-5. PubMed ID: 3738656
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Isolation of circulating immune complexes by conglutinin and separation of antigen from dissociated complexes by immobilized protein A.
    Gupta RC; Tan EM
    Clin Exp Immunol; 1981 Oct; 46(1):9-19. PubMed ID: 7337970
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immune complexes in primary biliary cirrhosis. Higher prevalence of circulating immune complexes in patients with associated autoimmune features.
    Gupta RC; Dickson ER; McDuffie FC; Baggenstoss AH
    Am J Med; 1982 Aug; 73(2):192-8. PubMed ID: 7114076
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Circulating immune complexes in infective endocarditis.
    Bayer AS; Theofilopoulos AN; Eisenberg R; Dixon FJ; Guze LB
    N Engl J Med; 1976 Dec; 295(27):1500-5. PubMed ID: 995157
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Circulating immune complexes and granulocytes chemotaxis in Kawasaki disease.
    Miyata K; Kawakami K; Onimaru T; Baba Y; Ono S; Hokonohara M; Yoshinaga M; Terawaki T
    Jpn Circ J; 1984 Dec; 48(12):1350-3. PubMed ID: 6512943
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Circulating immune complexes, complement factors C3, C4, C1-inhibitor, alpha-1-antitrypsin and immunoglobulins in asthmatic patients.
    Häfner GE; Wüthrich B; Grob PJ; Arrenbrecht S
    Respiration; 1981; 41(4):248-57. PubMed ID: 6975491
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Monomeric (7S) IgM in primary biliary cirrhosis.
    Taal BG; Schalm SW; de Bruyn AM; Kornman-vd Bosch HJ
    Scand J Gastroenterol; 1982 Mar; 17(2):173-5. PubMed ID: 6813951
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serum levels of immunoglobulin and complement in giant-cell arteritis.
    Malmvall BE; Bengtsson BA; Kaijser B; Nilsson LA; Alestig K
    JAMA; 1976 Oct; 236(16):1876-8. PubMed ID: 989540
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anticomplement receptor activity in the serum of patients with primary biliary cirrhosis.
    Minuk GY; Vergalla J; Hanson RG; Hoofnagle JH; Frank MM; Jones EA
    Gut; 1986 Mar; 27(3):324-8. PubMed ID: 3009280
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fate of circulating immune complexes in infective endocarditis.
    Cabane J; Godeau P; Herreman G; Acar J; Digeon M; Bach JF
    Am J Med; 1979 Feb; 66(2):277-82. PubMed ID: 154840
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative studies on immunoglobulins, complement component (C3), albumin, and immunoglobulin A-containing circulating immune complexes in serum and bile of patients with biliary obstruction.
    Ohshio G; Furukawa F; Manabe T; Tobe T; Hamashima Y
    Dig Dis Sci; 1988 May; 33(5):570-6. PubMed ID: 3282849
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Defects in serum attractant activity in different types of chronic liver disease.
    Yousif-Kadaru AG; Rajkovic IA; Wyke RJ; Williams R
    Gut; 1984 Jan; 25(1):79-84. PubMed ID: 6690377
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Circulating IgA immune complexes in AIDS.
    Lightfoote MM; Folks TM; Redfield R; Gold J; Sell KW
    Immunol Invest; 1985 Aug; 14(4):341-5. PubMed ID: 3877683
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Elevated IgG and decreased complement component C3 and factor B in B-thalassaemia major.
    Sinniah D; Yadav M
    Acta Paediatr Scand; 1981 Jul; 70(4):547-50. PubMed ID: 6914868
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cutaneous immunofluorescence in primary biliary cirrhosis.
    Randle HW; Millns JL; Schroeter AL; Winkelmann RK
    JAMA; 1981 Oct; 246(15):1679-81. PubMed ID: 6456364
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Is primary biliary cirrhosis an immune complex disease?
    Thomas HC; Potter BJ; Sherlock S
    Lancet; 1977 Dec; 2(8051):1261-3. PubMed ID: 73956
    [TBL] [Abstract][Full Text] [Related]  

  • 78. NIH conference. Primary biliary cirrhosis and the complement system.
    Ann Intern Med; 1979 Jan; 90(1):72-84. PubMed ID: 420467
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mononuclear cell complement receptor blockade in primary biliary cirrhosis.
    Al-Aghbar MN; Neuberger J; Williams R; Eddleston AL
    Gut; 1985 Jan; 26(1):20-5. PubMed ID: 3155513
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hypergammaglobulinemic purpura of Waldenström: characterization of circulating immune complexes.
    Serino G; Pitingolo F; Granatieri C; Maresca V; Invernizzi F; Zara C; Zanussi C
    Acta Haematol; 1983; 69(3):152-7. PubMed ID: 6404097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.